Inotek Pharmaceuticals Announces Poster Presentations on Trabodenoson at the American Glaucoma Society 2017 Annual Meeting

Source: Inotek Pharmaceuticals

Friday, February 24, 2017 | Conferences , Glaucoma , Inotek Pharmaceuticals


Inotek Pharmaceuticals announced three poster presentations at the American Glaucoma Society 2017 Annual Meeting to be held March 2-5 in Coronado, California. The presentation details are as follows:

  • Incidence of Hyperemia in the Trabodenoson Monotherapy Clinical Development Program Through Phase 2
    Poster #: 87
    Authors: C Rich, LJ Katz, C Murray, N Dgetluck, and R Baumgartner
    Date: Friday, March 3, 2017
    Time: 7:00am to 8:00am PST
  • Improved Function of Retinal Ganglion Cells by Topically Administered Trabodenoson in a Rat Model of Optic Nerve Crush Injury
    Poster #: 96
    Authors: A Brockman, D Albers, J Tsai, C Rich, R Baumgartner, and W McVicar
    Date: Friday, March 3, 2017
    Time: 7:00am to 8:00am PST
  • Further Elucidation of the Mechanism of Action of Trabodenoson Using Validated 3D-Human Trabecular Meshwork Constructs
    Poster #: 140
    Authors: D Albers, R Noecker, A Unser, F Ahmed, K Torrejon, R Baumgartner, and W McVicar
    Date: Saturday, March 4, 2017
    Time: 7:00am to 8:00am PST

Inotek will have an exhibition booth set up at #T27.


Comments

You must be logged in to leave a comment.